DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Lamisil (Terbinafine) - Published Studies

 
 



Lamisil Related Published Studies

Well-designed clinical trials related to Lamisil (Terbinafine)

Comparative study of 250 mg/day terbinafine and 100 mg/day itraconazole for the treatment of cutaneous sporotrichosis. [2011.05]

Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study. [2010.01]

The use of an intermittent terbinafine regimen for the treatment of dermatophyte toenail onychomycosis. [2009.03]

Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials. [2008.07]

Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: Results of two randomized, investigator-blinded, multicenter, international, controlled trials. [2008.03.29]

Effect of terbinafine and voriconazole on the pharmacokinetics of the antidepressant venlafaxine. [2008.02]

Pharmacokinetics and comparative bioavailability of two terbinafine hydrochloride formulations after single-dose administration in Chinese healthy subjects. [2008]

Terbinafine increases the plasma concentration of paroxetine after a single oral administration of paroxetine in healthy subjects. [2007.01]

The impact of aggressive debridement used as an adjunct therapy with terbinafine on perceptions of patients undergoing treatment for toenail onychomycosis. [2007]

Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study. [2006.11]

Treatment of toenail onychomycosis with oral terbinafine plus aggressive debridement: IRON-CLAD, a large, randomized, open-label, multicenter trial. [2006.11]

Voriconazole, but not terbinafine, markedly reduces alfentanil clearance and prolongs its half-life. [2006.11]

Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study. [2006.11]

Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus. [2006.11]

Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial. [2006.03]

Study of oral itraconazole and terbinafine pulse therapy in onychomycosis. [2006.01]

Intermittent versus continuous terbinafine in the treatment of toenail onychomycosis: a randomized, double-blind comparison. [2006]

Treatment of chronic rhinosinusitis with high-dose oral terbinafine: a double blind, placebo-controlled study. [2005.10]

Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial. [2005.10]

Ciclopirox topical solution, 8% combined with oral terbinafine to treat onychomycosis: a randomized, evaluator-blinded study. [2005.07]

Comparison of the clinical efficacy of oral terbinafine and ketoconazole combined with cephalexin in the treatment of Malassezia dermatitis in dogs--a pilot study. [2005.06]

Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis. [2005]

Treatment of Microsporum spp. tinea capitis with pulsed oral terbinafine. [2004.05]

Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day(-1)) in the treatment of cutaneous or lymphocutaneous sporotrichosis. [2004.02]

Treatment of tinea imbricata: a randomized clinical trial using griseofulvin, terbinafine, itraconazole and fluconazole. [2004.01]

Comparative bioavailability of two formulations of terbinafine. Data from a cross-over, randomised, open-label bioequivalence study in healthy volunteers. [2004]

Comparative efficacies of oral ketoconazole and terbinafine for reducing Malassezia population sizes on the skin of Basset Hounds. [2003.06]

Mupirocin vs terbinafine in impetigo. [2002.08]

A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species. [2002.05]

Drug efficacy of terbinafine hydrochloride (Lamisil) during oral treatment of cats, experimentally infected with Microsporum canis. [2002.04]

Terbinafine in the treatment of Trichophyton tinea capitis: a randomized, double-blind, parallel-group, duration-finding study. [2002.04]

An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis. [2002.03]

Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study. [2002.03]

Reactivity to trichophytin antigen in patients with onychomycosis: effect of terbinafine. [2002.03]

Long-term results in patients with onychomycosis treated with terbinafine or itraconazole. [2002.02]

Cost effectiveness of oral terbinafine (Lamisil) compared with oral fluconazole (Diflucan) in the treatment of patients with toenail onychomycosis. [2002]

Terbinafine quantification in human plasma by high-performance liquid chromatography coupled to electrospray tandem mass spectrometry: application to a bioequivalence study. [2001.12]

Topical amorolfine for 15 months combined with 12 weeks of oral terbinafine, a cost-effective treatment for onychomycosis. [2001.10]

Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole. [2001.09]

One week terbinafine 1% cream (Lamisil) once daily is effective in the treatment of interdigital tinea pedis: a vehicle controlled study. LAS-INT-06 Study Group. [2001.08]

Short-duration oral terbinafine for the treatment of tinea pedis in HIV-positive patients. [2001.07]

Safety and efficacy of short-duration oral terbinafine for the treatment of tinea corporis or tinea cruris in subjects with HIV infection or diabetes. [2001.07]

Evaluation of the efficacy and tolerability of oral terbinafine (Daskil) in patients with seborrhoeic dermatitis. A multicentre, randomized, investigator-blinded, placebo-controlled trial. [2001.04]

Efficacy and safety of terbinafine 1% solution in the treatment of interdigital tinea pedis and tinea corporis or tinea cruris. [2001.03]

Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis. [2001.03]

A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis. [2001.02]

Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study. [2001]

[One-week application of terbinafine cream compared with four-week application in treatment of Tinea pedis] [2001]

Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes. [2001]

Cost effectiveness of continuous terbinafine compared with intermittent itraconazole in the treatment of dermatophyte toenail onychomycosis: an analysis of based on results from the L.I.ON. study. Lamisil versus Itraconazole in Onychomycosis. [2001]

Efficacy of ajoene in the treatment of tinea pedis: a double-blind and comparative study with terbinafine. [2000.11]

A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region. [2000.06]

Comparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporis. [2000.03]

A double-blind, randomized study to compare the efficacy and safety of terbinafine (Lamisil) with fluconazole (Diflucan) in the treatment of onychomycosis. [2000.01]

Comparison of terbinafine and griseofulvin in the treatment of tinea capitis. [2000.01]

L.I.ON. Study: efficacy and tolerability of continuous terbinafine (Lamisil) compared to intermittent itraconazole in the treatment of toenail onychomycosis. Lamisil vs. Itraconazole in Onychomycosis. [1999.11]

Topical treatment of interdigital tinea pedis: terbinafine compared with clotrimazole. [1999.11]

Double-blind study of the efficacy of 1 week topical terbinafine cream compared to 4 weeks miconazole cream in patients with tinea pedis. [1999.10]

Itraconazole pulse therapy vs continuous terbinafine dosing for toenail onychomycosis. [1999.07]

Ajoene in the topical short-term treatment of tinea cruris and tinea corporis in humans. Randomized comparative study with terbinafine. [1999.06]

Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis. [1999.05]

Double blind, randomised study of continuous terbinafine compared with intermittent itraconazole in treatment of toenail onychomycosis. The LION Study Group. [1999.04.17]

Short duration treatment with terbinafine for tinea capitis caused by Trichophyton or Microsporum species. The Study Group. [1999.03]

The evolving role of itraconazole, fluconazole and terbinafine in the treatment of tinea capitis. [1999.02]

Efficacy and tolerability of terbinafine 1% topical solution used for 1 week compared with 4 weeks clotrimazole 1% topical solution in the treatment of interdigital tinea pedis: a randomized, double-blind, multi-centre, 8-week clinical trial. [1999]

Comparison of one week of oral terbinafine (250 mg/day) with four weeks of treatment with clotrimazole 1% cream in interdigital tinea pedis. [1998.10]

A double-blind, randomized, comparative trial of itraconazole versus terbinafine for 2 weeks in tinea capitis. [1998.10]

Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks. [1998.09]

Absence of effect of terbinafine on the activity of CYP1A2, NAT-2, and xanthine oxidase. [1998.05]

Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day. [1998.05]

Terbinafine versus itraconazole: a controlled clinical comparison in onychomycosis of the toenails. [1998.05]

Effect of terbinafine on theophylline pharmacokinetics in healthy volunteers. [1998.03]

Griseofulvin and terbinafine in the treatment of tinea capitis in children. [1998.02.27]

Short-term itraconazole versus terbinafine in the treatment of tinea pedis or manus. [1998.02]

Long-term follow up of patients with toenail onychomycosis after treatment with terbinafine. [1998.02]

Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial. [1997.11]

Effects of terbinafine on the pharmacokinetics of digoxin in healthy volunteers. [1997.07]

Evaluation of effects of terbinafine on single oral dose pharmacokinetics and anticoagulant actions of warfarin in healthy volunteers. [1997.07]

Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy. The Lagos V Study Group. [1997.05]

The effect of food on the pharmacokinetics of multiple-dose terbinafine in young and elderly healthy subjects. [1997.03]

Oral terbinafine in toenail dermatophytosis. A double-blind, placebo-controlled multicenter study with 12 months' follow-up. [1997.01]

The efficacy of a topical application of terbinafine 1% solution in subjects with pityriasis versicolor: a placebo-controlled study. [1997]

Pityriasis versicolor: clinical experience with Lamisil cream and Lamisil DermGel. [1997]

[Terbinafine versus miconazole in patients with tinea pedis] [1996.08.03]

A randomized double-blind comparative study of terbinafine for 1, 2 and 4 weeks in tinea capitis. [1996.07]

German randomized double-blind multicentre comparison of terbinafine and itraconazole for the treatment of toenail tinea infection. [1996.06]

A 12-week treatment for dermatophyte toe onychomycosis: terbinafine 250 mg/day vs. itraconazole 200 mg/day--a double-blind comparative trial. [1996.06]

Intermittent therapy with terbinafine for dermatophyte toe-onychomycosis: a new approach. [1996.04]

Fluconazole, but not terbinafine, enhances the effects of triazolam by inhibiting its metabolism. [1996.04]

Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy. [1996.04]

Safe coadministration of terbinafine and terfenadine: a placebo-controlled crossover study of pharmacokinetic and pharmacodynamic interactions in healthy volunteers. [1996.03]

Pharmacokinetics of terbinafine and of its five main metabolites in plasma and urine, following a single oral dose in healthy subjects. [1995.11]

Terbinafine in onychomycosis of the toenail: a novel treatment protocol. [1995.11]

Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study Group. [1995.10.07]

Nail incorporation kinetics of terbinafine in onychomycosis patients. [1995.09]

Effect of itraconazole and terbinafine on the pharmacokinetics and pharmacodynamics of midazolam in healthy volunteers. [1995.09]

Treatment of toenail onychomycosis. A randomized, double-blind study with terbinafine and griseofulvin. LAGOS II Study Group. [1995.08]

Double-blind, parallel-group comparison of terbinafine and griseofulvin in the treatment of toenail onychomycosis. [1995.05]

A comparison of 2 weeks of terbinafine 250 mg/day with 4 weeks of itraconazole 100 mg/day in plantar-type tinea pedis. [1995.04]

Antifungal activity of itraconazole and terbinafine in human stratum corneum: a comparative study. [1995.03]

Open randomized comparison of itraconazole versus terbinafine in onychomycosis. [1995.02]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017